XHR2XGAReplacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- Billable / Specific Code
XHR2XGA is a billable ICD-10-PCS procedure code for Replacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 018. The root operation Replacement involves putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Skin graft.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | H | Skin, Subcutaneous Tissue, Fascia and Breast |
| 3 | Operation | R | Replacement |
| 4 | BodyPart | 2 | Skin, Abdomen |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | G | Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy |
| 7 | Qualifier | A | New Technology Group 10 |
In the ICD-10-PCS Alphabetic Index
These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:
To code prademagene zamikeracel of the abdomen genetically engineered autologous cell therapy, open the FY 2027 ICD-10-PCS Alphabetic Index at Prademagene Zamikeracel, then the subterms Genetically Engineered Autologous Cell Therapy, Abdomen. The entry lists XHR2XGA directly as a complete, billable code.
Clinical Classification (CCSR)
AHRQ groups this procedure code into these clinical categories.
Code History
- 0HR7X73 — Replace Abd Skin w Autol Sub, Full Thick, Extern
Similar Procedure Codes
Questions About XHR2XGA
Is XHR2XGA a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Replacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 on inpatient claims from October 1, 2026 through September 30, 2027.
What is the ICD-10-PCS code for prademagene zamikeracel of the abdomen genetically engineered autologous cell therapy?
The FY 2027 ICD-10-PCS Alphabetic Index entry Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, Abdomen is a direct entry for XHR2XGA, Replacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10, billable on inpatient claims from October 1, 2026 through September 30, 2027.
What do the characters in XHR2XGA mean?
The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character H is the Body System (Skin, Subcutaneous Tissue, Fascia and Breast); the 3rd character R is the Operation (Replacement); the 4th character 2 is the BodyPart (Skin, Abdomen); the 5th character X is the Approach (External); the 6th character G is the Device/Substance/Technology (Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy); the 7th character A is the Qualifier (New Technology Group 10).
What MS-DRG does XHR2XGA group to?
On an inpatient stay, Replacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 maps to MS-DRG 018 (chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies). The MS-DRG sets the fixed Medicare payment for the stay.
